InvestorsHub Logo
Followers 231
Posts 38584
Boards Moderated 0
Alias Born 03/12/2015

Re: None

Tuesday, 05/30/2017 10:41:07 PM

Tuesday, May 30, 2017 10:41:07 PM

Post# of 10325
$BIEL with their Patented Actipatch is entering a 36 billion dollar business with their Migraines clinical trial.

THIS IS GOING TO BE HUGE

BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)

http://www.otcmarkets.com/stock/BIEL/news/BioElectronics-Announces-Independent-Migraine-Clinical-Study--Migraine-Prevention-Using-ActiPatch--Pulsed-Shortwave-Therapy-?id=160386

http://exploreplasticsurgery.com/bioelectronics-migraine-device-study/
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.